4Weiss LR. Open-label, randomized comparison of the efficacy and tolerability of clarithromycin, levofloxacin, and cefuroxime axetil in the treatment of adults with acute bacterial exacerbations of chronic bronchitis[J]. Clin Ther, 2002, 24(9): 1414-1425.
5Shah PM, Maesen FP, Dolmann A, et al. Levofloxacin versus cefuroxime axetil in the treatment of acute exacerbation of chronic bronchitis : results of a randomized, double-blind study[J]. J Antimicrob Chemother, 1999, 43(4): 529-539.
6Norrby SR, Petermann W, Willcox PA, et al. A comparative study of levofloxacin and ceftriaxone in the treatment of hospitalized patients with pneumonia[J]. Scand J Infect Dis, 1998,30(4) : 397-404.
7Decousser JW, Allouch PY, Courvalin P, et al. In vitro activity of moxifloxacin against recent community-acquired respiratory tract pathogens isolated in France : a national survey[J]. Int J Antimicrob Agents, 2002, 20(3): 186-195.
8Hurst M, Lamb HM, Scott LJ, et al. Levofloxacin: an updated review of its use in the treatment of bacterial infections[J].Drugs 2002, 62(14): 2127-2167.
9File TK Jr. Levofloxacin in the treatment of community acquired pneumonia[J]. Can Respir J, 1999, 6(Suppl A): 35.
